PEOPLE - Bioject (US) makes appointment:
This article was originally published in Clinica
Developer of needle-free drug delivery systems Bioject (Bedminster, New Jersey) has appointed Eric Mishkin as senior vice-president and chief scientific officer. Dr Mishkin, who has over 25 years of experience in immunology research and microbiology, most recenly served as director of immunology research at Wyeth-Ayerst. It has also announced the appointment of Chris Pugh, who has over 10 years of product and business development experience, as director of business development.